Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:32 PM
Ignite Modification Date:
2025-12-24 @ 11:32 PM
NCT ID:
NCT01622556
Eligibility Criteria:
Inclusion Criteria:
Subjects 18-70 years old. ECOG 0-2
Patients must have a diagnosis of one of the following:
* Chronic Myeloid Leukemia
* Acute Myeloid Leukemia
* Acute Lymphoblastic Leukemia
* Hodgkin's Disease
* Non-Hodgkins Lymphoma
* Myelodysplastic Syndromes
* Myeloproliferative Disorder
Patients must have adequate visceral organ function
* Patients must furnish written informed consent and HIPAA authorization for release of personal health information.
* Patients must be able to understand the requirements of the study, abide by the study restrictions, and agree to return for the required assessments.
Exclusion Criteria:
* Patients who have a histocompatible sibling-matched donor age 18 to 65 years in good health who is willing to donate stem cells are ineligible.
* Patients who are pregnant are ineligible.
* Patients are ineligible if they have received cumulative chemotherapy doses in excess of: carmustine (BCNU) 400 mg/m2, and/or a cumulative anthracycline exposure in excess of 550 mg/m2 doxorubicin (Adriamycin®) unless gated-pool radionuclide cardiac scan shows greater than/equal to 45% ejection fraction.
Patients who are HIV or HTLV-I, -II antibody sero-positive are ineligible.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT01622556
Study Brief:
Protocol Section:
NCT01622556